Drugs / S-303 Treated Red Blood Cells (RBCs)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01740531 | Dec 2012 → Dec 2017 | beta-thalassemia major | Cerus Corporation | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | S-303 Treated Red Blood Cells (RBCs) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01740531 ↗ |